Integrated Biopharma, Inc.
INBP
$0.32
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 123.00K | -178.00K | 611.00K | 116.00K | 259.00K |
| Total Depreciation and Amortization | 327.00K | 327.00K | 304.00K | 318.00K | 320.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 120.00K | 854.00K | 258.00K | 125.00K | 253.00K |
| Change in Net Operating Assets | 731.00K | -412.00K | -557.00K | -358.00K | -175.00K |
| Cash from Operations | 1.30M | 591.00K | 616.00K | 201.00K | 657.00K |
| Capital Expenditure | -173.00K | 10.00K | -116.00K | -29.00K | -56.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -14.00K | -- | -- | -- |
| Cash from Investing | -173.00K | -4.00K | -116.00K | -29.00K | -56.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -11.00K | -1.00K | 0.00 | 0.00 | -7.00K |
| Issuance of Common Stock | -- | 68.00K | 0.00 | 18.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -11.00K | 67.00K | 0.00 | 18.00K | -7.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.12M | 654.00K | 500.00K | 190.00K | 594.00K |